Related Experiment Video
Updated: May 11, 2026
Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
[Therapeutic approaches for retinitis pigmentosa]
1Department für Augenheilkunde, Universitätsklinikum Tübingen, Schleichstrasse 12, Tübingen. pach.johanna@googlemail.com
Background:
Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous group of hereditary retinal disorders, which lead to progressive loss of vision and finally blindness. Yet there is no approved therapy. Advances in unravelling underlying genetic disorders and pathophysiological mechanisms offer new therapeutic approaches of which some are summarised in this review.
Methods:
We performed a systematic literature research for defined key words in PubMed.
Results:
New approaches to therapy for RP include: gene therapy, pharmacological treatment, neuroprotection, electrical stimulation, retinal prostheses, retinal transplantation and optogenetic therapy.
Conclusions:
Recently there have been advances in new approaches for therapy of dystrophic retinal diseases. Advances in the different approaches are being made at different rates. Although there is no approved therapy yet, the future for treating RP at least in some patients looks promising.